Molecular study of chromosome 15 in 22 patients with Angelman syndrome.
DNA studies in 22 families with Angelman syndrome (AS) were performed using the chromosome 15 marker loci D15S9, D15S10, D15S11, D15S12, D15S13, D15S18, D15S24, D15S86, the alpha-actin gene and the GABA beta 3 receptor gene (GABRB3). Uniparental disomy of chromosome 15 was excluded in all patients. Eighteen AS patients (82%) showed a molecular deletion of chromosome 15q11-q13 with one or more of these markers. No duplications of junction fragments, bridging deletions or duplication breakpoints were observed. The GABRB3 gene was deleted in all deletion-positive patients tested. Analysis of maternal DNA indicated that each deletion was a de novo event. All deletions were of maternal origin; this is in agreement with genomic imprinting in AS.
Beuten
J
J
Department of Genetics, University of Antwerp, Belgium.
Mangelschots
K
K
Buntinx
I
I
Coucke
P
P
Brouwer
O F
OF
Hennekam
R C
RC
Van Broeckhoven
C
C
Willems
P J
PJ
D000199:Actins / Q000235:genetics; D000293:Adolescent; D000328:Adult; D017204:Angelman Syndrome / Q000235:genetics*; D002648:Child; D002675:Child, Preschool; D002872:Chromosome Deletion; D002884:Chromosomes, Human, Pair 15; D004252:DNA Mutational Analysis; D003720:Densitometry; D005260:Female; D017353:Gene Deletion; D005819:Genetic Markers; D006801:Humans; D008297:Male; D009035:Mothers; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D011963:Receptors, GABA-A / Q000235:genetics; D015183:Restriction Mapping; D017384:Sequence Deletion
D000199:Actins; D005819:Genetic Markers; D011963:Receptors, GABA-A